Yoo Kwai Han
Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Blood Res. 2022 Apr 30;57(S1):75-78. doi: 10.5045/br.2022.2022055.
The accurate assessment of initial disease status and therapeutic responses is critical to the optimal management of patients with lymphoma. Currently, staging and treatment response evaluation for lymphoma has been standardized into the Lugano classification. Lugano classification incorporates positron emission tomography (PET) into the existing response criteria, and response assessment using FDG-PET/CT has been proven to predict the prognosis in various lymphoma subtypes effectively. We will briefly review the current staging and response evaluation system and explore the role of functional imaging in the field of lymphoma.
准确评估初始疾病状态和治疗反应对于淋巴瘤患者的最佳管理至关重要。目前，淋巴瘤的分期和治疗反应评估已标准化为卢加诺分类。卢加诺分类将正电子发射断层扫描（PET）纳入现有的反应标准，并且已证明使用氟脱氧葡萄糖PET/CT进行反应评估可有效预测各种淋巴瘤亚型的预后。我们将简要回顾当前的分期和反应评估系统，并探讨功能成像在淋巴瘤领域中的作用。
